These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21762806)

  • 21. HIV-1 matrix mutations that alter gag membrane binding modulate mature core formation and post-entry events.
    Hikichi Y; Takeda E; Fujino M; Nakayama E; Matano T; Murakami T
    Virology; 2019 Jun; 532():97-107. PubMed ID: 31055063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural and biophysical characterizations of HIV-1 matrix trimer binding to lipid nanodiscs shed light on virus assembly.
    Murphy RE; Samal AB; Vlach J; Mas V; Prevelige PE; Saad JS
    J Biol Chem; 2019 Dec; 294(49):18600-18612. PubMed ID: 31640987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 Gag.
    Inlora J; Chukkapalli V; Derse D; Ono A
    J Virol; 2011 Apr; 85(8):3802-10. PubMed ID: 21289126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles played by acidic lipids in HIV-1 Gag membrane binding.
    Olety B; Ono A
    Virus Res; 2014 Nov; 193():108-15. PubMed ID: 24998886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trio engagement via plasma membrane phospholipids and the myristoyl moiety governs HIV-1 matrix binding to bilayers.
    Vlach J; Saad JS
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3525-30. PubMed ID: 23401539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between HIV-1 Gag Multimerization and Membrane Binding.
    Sumner C; Ono A
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphatidylinositol-(4,5)-Bisphosphate Acyl Chains Differentiate Membrane Binding of HIV-1 Gag from That of the Phospholipase Cδ1 Pleckstrin Homology Domain.
    Olety B; Veatch SL; Ono A
    J Virol; 2015 Aug; 89(15):7861-73. PubMed ID: 25995263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.
    Chazal N; Gay B; Carrière C; Tournier J; Boulanger P
    J Virol; 1995 Jan; 69(1):365-75. PubMed ID: 7983731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myristate exposure in the human immunodeficiency virus type 1 matrix protein is modulated by pH.
    Fledderman EL; Fujii K; Ghanam RH; Waki K; Prevelige PE; Freed EO; Saad JS
    Biochemistry; 2010 Nov; 49(44):9551-62. PubMed ID: 20886905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation.
    Murphy RE; Saad JS
    Viruses; 2020 May; 12(5):. PubMed ID: 32429351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions.
    Scarlata S; Ehrlich LS; Carter CA
    J Mol Biol; 1998 Mar; 277(2):161-9. PubMed ID: 9514761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific inter-domain interactions stabilize a compact HIV-1 Gag conformation.
    Lin C; Mendoza-Espinosa P; Rouzina I; Guzmán O; Moreno-Razo JA; Francisco JS; Bruinsma R
    PLoS One; 2019; 14(8):e0221256. PubMed ID: 31437199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solution structure of calmodulin bound to the binding domain of the HIV-1 matrix protein.
    Vlach J; Samal AB; Saad JS
    J Biol Chem; 2014 Mar; 289(12):8697-705. PubMed ID: 24500712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The C-terminal p6 domain of the HIV-1 Pr55
    Dubois N; Khoo KK; Ghossein S; Seissler T; Wolff P; McKinstry WJ; Mak J; Paillart JC; Marquet R; Bernacchi S
    RNA Biol; 2018; 15(7):923-936. PubMed ID: 29954247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenging the Existing Model of the Hexameric HIV-1 Gag Lattice and MA Shell Superstructure: Implications for Viral Entry.
    Santos JRL; Sun W; Mangukia TA; Reyes-Serratos E; Marcet-Palacios M
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Determinants Directing HIV-1 Gag Assembly to Virus-Containing Compartments in Primary Macrophages.
    Inlora J; Chukkapalli V; Bedi S; Ono A
    J Virol; 2016 Oct; 90(19):8509-19. PubMed ID: 27440886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.
    Saad JS; Miller J; Tai J; Kim A; Ghanam RH; Summers MF
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11364-9. PubMed ID: 16840558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The HIV-1 nucleocapsid protein recruits negatively charged lipids to ensure its optimal binding to lipid membranes.
    Kempf N; Postupalenko V; Bora S; Didier P; Arntz Y; de Rocquigny H; Mély Y
    J Virol; 2015 Feb; 89(3):1756-67. PubMed ID: 25410868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Point mutations in the HIV-1 matrix protein turn off the myristyl switch.
    Saad JS; Loeliger E; Luncsford P; Liriano M; Tai J; Kim A; Miller J; Joshi A; Freed EO; Summers MF
    J Mol Biol; 2007 Feb; 366(2):574-85. PubMed ID: 17188710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HIV-1 matrix protein does not interact directly with the protein interactive domain of AP-3δ.
    Kyere SK; Mercredi PY; Dong X; Spearman P; Summers MF
    Virus Res; 2012 Nov; 169(2):411-4. PubMed ID: 22705971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.